Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Bone Marrow Transplantation
|
October 1, 1993
Autologous bone marrow transplantation for acute lymphoblastic leukemia
K Doney, C D Buckner, L Fisher, et al.
Bone Marrow Transplantation
|
January 1, 1992
Late complications of allogeneic and autologous marrow transplantation
K M Sullivan, M Mori, J Sanders, et al.
Bone Marrow Transplantation
|
January 1, 1989
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation
R S Hill, P Mazza, D Amos, et al.
The New England Journal of Medicine
|
January 26, 1989
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma
C Anasetti, D Amos, P G Beatty, et al.
Bone Marrow Transplantation
|
October 25, 2016
Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas
J Gauthier, L Holmberg, D Wu, et al.
Bone Marrow Transplantation
|
December 1, 1994
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia
C H Weaver, R A Clift, H J Deeg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1993
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens
J P Radich, J E Sanders, C D Buckner, et al.
Bone Marrow Transplantation
|
August 5, 2000
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer
F Gutierrez-Delgado, L A Holmberg, H Hooper, et al.
Blood
|
December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
L A Holmberg, M Boeckh, H Hooper, et al.
Leukemia
|
April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
P Hari, M-V Mateos, R Abonour, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Bone Marrow Transplantation
|
October 1, 1993
Autologous bone marrow transplantation for acute lymphoblastic leukemia
K Doney, C D Buckner, L Fisher, et al.
Bone Marrow Transplantation
|
January 1, 1992
Late complications of allogeneic and autologous marrow transplantation
K M Sullivan, M Mori, J Sanders, et al.
Bone Marrow Transplantation
|
January 1, 1989
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation
R S Hill, P Mazza, D Amos, et al.
The New England Journal of Medicine
|
January 26, 1989
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma
C Anasetti, D Amos, P G Beatty, et al.
Bone Marrow Transplantation
|
October 25, 2016
Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas
J Gauthier, L Holmberg, D Wu, et al.
Bone Marrow Transplantation
|
December 1, 1994
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia
C H Weaver, R A Clift, H J Deeg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1993
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens
J P Radich, J E Sanders, C D Buckner, et al.
Bone Marrow Transplantation
|
August 5, 2000
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer
F Gutierrez-Delgado, L A Holmberg, H Hooper, et al.
Blood
|
December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
L A Holmberg, M Boeckh, H Hooper, et al.
Leukemia
|
April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
P Hari, M-V Mateos, R Abonour, et al.
Page
of 6